Artículos del autor

solaci

Day 3

IN-PACT CORO: OCT validation of drug-eluting balloons

Drug-eluting balloons could reduce intimal hyperplasia detected by OCT in intmerventions with conventional stents. 30 patients were...
solaci -
Day 3

Treatment of in-stent restenosis with drug-eluting balloon

ISAR-DESIRE 3 did not show that paclitaxel-eluting balloon may be useful for treating restenosis of a sirolimus-eluting...
solaci -
Day 3

ELISA 3: Early vs. late invasive strategy in patients without high-risk ST elevation

The invasive strategy is preferred to treat patients with acute coronary syndromes without ST-segment elevation, but the...
solaci -
Day 3

ADVISE II: functional assessment of coronary lesions without adenosine

The pressure ratio in the resting phase of the cardiac cycle is a newly Introduced procedure for...
solaci -
Day 3

RENAL DES: reduction of restenosis in patients with kidney failure

Coronary angioplasty in patients with kidney failure is associated with an increased occurrence of events. This study...
solaci -
Day 3

ORBIT II: new atherectomy device

The objective of the study was to test the use of a new atherectomy device to prepare...
solaci -
Day 3

J- REVERSE: sirolimus-eluting vs. everolimus-eluting stent in bifurcation lesions

Asymmetrical expansion of the stent produces an uneven neointimal growth and increases the risk of thrombosis. The...
solaci -
Day 3

Pre-dilation of side branch during percutaneous treatment of bifurcation lesions

The simple strategy with a provisional stent is now favored to treat bifurcation lesions; however, stent implantation...
solaci -